Abstract:Objectives: Dementia is becoming a major health problem in the world, and chronic brain ischemia is an established important risk factor in predisposing this disease. Astrocytes, as one major part of the blood–brain barrier (BBB), are activated during chronic cerebral blood flow hypoperfusion. Reactive astrocytes have been classified into phenotype pro-inflammatory type A1 or neuroprotective type A2. However, the specific subtype change of astrocyte and the mechanisms of chronic brain ischemia are still unknown. Methods: In order to depict the phenotype changes and their possible roles during this process, a rat bilateral common carotid artery occlusion model (BCAO) was employed in the present study. Meanwhile, the signaling pathways that possibly regulate these changes were investigated as well. Results: After four-week occlusion, astrocytes in the cortex of BCAO rats were shown to be the A2 phenotype, identified by the significant up-regulation of S100a10 accompanied by the down-regulation of Connexin 43 (CX43) protein. Next, we established in vitro hypoxia models, which were set up by stimulating primary astrocyte cultures from rat cortex with cobalt chloride, low glucose, or/and fibrinogen. Consistent with in vivo data, the cultured astrocytes also transformed into the A2 phenotype with the up-regulation of S100a10 and the down-regulation of CX43. In order to explore the mechanism of CX43 protein changes, C6 astrocyte cells were handled in both hypoxia and low-glucose stimulus, in which decreased pERK and pJNK expression were found. Conclusions: In conclusion, our data suggest that in chronic cerebral ischemia conditions, the gradual ischemic insults could promote the transformation of astrocytes into A2 type instead of A1 type, and the phosphorylation of CX43 was negatively regulated by the phosphorylation of ERK and JNK. Also, our data could provide some new evidence of how to leverage the endogenous astrocytes phenotype changes during CNS injury by promoting them to be "protector" and not "culprit".

A1/A2 astrocytes in central nervous system injuries and diseases: Angels or devils?

[Role of Astrocytes in Sensory Processing in Central Nervous System].

Astrocytes: a double-edged sword in neurodegenerative diseases

Protective Functions of Reactive Astrocytes Following Central Nervous System Insult

Reactive Astrocytes in Neurodegenerative Diseases

Astrocytes: biology and pathology

Neurotoxic reactive astrocytes are induced by activated microglia

Astrocyte-Mediated Neuroinflammation in Neurological Conditions

Astrocytes in human central nervous system diseases: a frontier for new therapies

The Phenotype Changes of Astrocyte During Different Ischemia Conditions

Functions of Astrocytes under Normal Conditions and after a Brain Disease

The dual role of astrocyte activation and reactive gliosis

Astroglial activation: Current concepts and future directions

Diversity of Reactive Astrogliosis in CNS Pathology: Heterogeneity or Plasticity?

Emerging roles of astrocytes as immune effectors in the central nervous system

Astrocyte polarization in glaucoma: a new opportunity

Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration

The function of astrocytes and their role in neurological diseases

The Role of Astrocytes in Oxidative Stress of Central Nervous System: A Mixed Blessing

The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases

An update on reactive astrocytes in chronic pain